Table S1. List of hiPSC lines used. Table S2. Number of identified genes in each sample, related to results section regarding RNA sequencing. Table S3. The 20 most significantly differentially expressed genes at 24 h of hiPSC culture with or without insulin, related to results section regarding RNA sequencing. The list is ordered by adjusted p values. Average read counts of samples with no insulin treatment are shown in the “baseMean” column. Fold change is the log2 fold change of normalized read count per gene between groups. Followed are the lfcSE (log fold change Standard Error) and stat (Wald statistics). Also listed are p values and adjusted p values corrected for multiple testing using the Benjamini-Hochberg False Discovery Rate (FDR) approach. Table S4. The 20 most significantly differentially expressed genes at 72 h of hiPSC culture with or without insulin, related to results section regarding RNA sequencing. The list is ordered by adjusted p values. Average read counts of samples with no insulin treatment are shown in the “baseMean” column. Fold change is the log2 fold change of normalized read count per gene between groups. Followed are the lfcSE (log fold change Standard Error) and stat (Wald statistics). Also listed are p values and adjusted p values corrected for multiple testing using the Benjamini-Hochberg False Discovery Rate (FDR) approach. Table S5. The top 100 significant GO (biological process) terms associated with differentially expressed transcripts after 72 h of hiPSC culture with or without insulin, related to results sections regarding RNA sequencing. Table S6. Differentially expressed genes from culture of hiPSCs with or without insulin that have been identified as a part of KEGG signaling pathways regulating pluripotency of stem cells (human). Table S7. Differentially expressed genes from culture of hiPSCs with or without insulin that have been identified as a part of KEGG insulin signaling pathway (human). (DOCX 74 kb)